Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for MYCOPHENOLIC ACID
- Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
- Belatacept as a Replacement for CNIs 3 to 12 Months Post-transplantation in Patients With Early Graft Dysfunction
- Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies
- An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant Recipients
- Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma
- Open-label Extension Study of Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Lupus Nephritis
- Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients
- COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
- Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response
- Cyclosporine on Day Zero as Prophylaxis for Cytokine Release Syndrome
- Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR
- A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease
- Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function
- Reduced Intensity BMT for Immune Dysregulatory and Bone Marrow Failure Syndromes Using Post-Transplant Cyclophosphamide
- CNI Transient Replacement by Belatacept From 3 to 12 Months Post Transplantation in Patients With Early Graft Dysfunction
- RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients
- CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients
- Once Daily Immunosuppression Regimen
- Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients
- Evaluation of Desensitization Protocols in HLA-incompatible Kidney-transplant Candidates
- Sirolimus-based Immunosuppression Treatment Regimen for Liver Transplantation
- Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients
- Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid.
- Budesonide for Mycophenolic Acid-induced Diarrhea in Renal Transplant Recipients
- Omental Islet Transplant
- Safety, Tolerability and Pharmacokinetics of Oral CellCept (Mycophenolate Mofetil) in Pediatric Liver Transplant Recipients on Concomitant Treatment With Cyclosporine and Corticosteroids
- A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)
- Liver Immunosuppression Free Trial
- The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear
- Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients
- Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic A
- Synergetic B-cell Immodulation in SLE
- Belatacept 3 Month Post Transplant Conversion Study
- Belatacept in Kidney Transplantation of Moderately Sensitized Patients
- Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA Following Liver Transplantation
- Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
- Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring
- Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients
- Everolimus Post Orthotopic Liver Transplant
- Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.
- Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients
- Imatinib Mesylate and Mycophenolate Mofetil for Steroid-Refractory Sclerotic/Fibrotic cGVHD in Children
- MPA Pharmacokinetics in Renal Transplantation
- A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys
- 12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients
- A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS)
- Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
- Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS
- Belatacept Early Steroid Withdrawal Trial
- Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation
- Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients
- Crohn's Allogeneic Transplant Study
- Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen
- Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention
- Myfortic, Prograf, and Corticosteroids in de Novo Liver Transplantation
- Tacrolimus Versus Cyclosporine for Immunosuppression After Lung Transplantation
- Advagraf/Prograf Conversion Trial
- Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients
- Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
- Clinical Trial Treatment in Lupus Nephritis
- Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation
- Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome
- 24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients
- Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patients
- Myfortic for the Treatment of Non-infectious Intermediate Uveitis
- Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fasting Condition
- Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed Condition
- Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients
- Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation
- Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)
- Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis
- A Pharmacokinetic Study of CellCept (Mycophenolate Mofetil) Versus Mycophenolate Sodium in Kidney Transplant Patients
- Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients
- The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis
- Study of CellCept for Advanced Pancreatic Cancer
- Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis
- Intensified Dosing of Cellcept (Mycophenolate Mofetil) in Kidney Transplantation
- Effects of Mycophenolate Mofetil in Cystic Fibrosis Lung Transplant Patients
- Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation
- Mycophenolate Mofetil for IgA Nephropathy
- A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients
- CLEAR Study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants
- CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients
- Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic
- Thymoglobulin in Calcineurin Inhibitor and Steroid Minimization Protocol
- A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms
- Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®
- Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis
- Pharmacokinetic Profile of Myfortic in Combination With Tacrolimus in Fed Versus Fasting State
- 24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients
- Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome
- Myfortic vs. Cellcept in Kidney Transplant Recipients
- Myfortic Versus Azathioprine in Systemic Lupus Erythematosus
- Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine Inhibitors
- Etanercept for the Treatment of Lupus Nephritis
- Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients
- Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients
- Gastrointestinal and Health-related Quality of Life in Kidney Transplant Patients Treated With Mycophenolate Mofetil
- Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Microemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients
- Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.
- MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis
- Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN
- Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)
- Steroid Free Immunosuppression in Liver Transplantation
- Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids
- PK-PD Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients
- Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients
- Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation
- MMF and Calcineurin Inhibitor Withdrawal in CAN
- Pharmacokinetics of Mmf and Valganciclovir
- Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney Transplant
- MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression
- Pilot Trial for Implementation of a MPA PK Monitoring Strategy
- Enteric Coated Myfortic for Liver Transplant Recipients
- Fixed Dose MMF vs Concentration Controlled MMF After Renal Transplantation
- Outcomes in Pediatric Heart Transplant Recipients Receiving Cellcept
- Pharmacokinetics of Mycophenolate Mofetil in Healthy Volunteers
- Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV Treatment
- Study of the Pharmacokinetics of Mycophenolate Mofetil in Patients Who Have Undergone Orthotopic Liver Transplantation
Clinical trials list
click for details